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Abstract
Monoterpenes are the naturally occurred essential oils in various plant 
species having a wide range of biological activities. Attentions on the 
natural compounds, especially those are plant-derived is growing day 
by day. Nerol, a monoterpene having some important biological acti-
vities along with its other applications, may be a hopeful tool in this 
context. By considering the above circumstances, this study aimed to 
perform a scientific and technological prospective study on this char-
ming monoterpene with an emphasis on the treatment of neglected 
diseases along with other monoterpenes. We conducted a compre-
hensive and systematic search for published articles, periodicals, ma-
gazines in the CAPES, ScienceDirect and Pubmed, while for patents 
we have gone through search in National Institute of Industrial Pro-
perty of Brazil (INPI), European Patent Office (EPO), World Intellectual 
Property Organization (WIPO) and United States Patent and Trademark 
Office (USPTO). Results suggesting monoterpenes have therapeutic 
potentials against malaria, dengue, schistosomiasis, tuberculosis, le-
prosies, leishmaniasis and chagas diseases. Nerol has anti-tuberculosis 
potential. In conclusion, more researches are recommenced with nerol 
in a context of treatment of neglected diseases.
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Introduction 
Nowadays, natural products are in a great attention to the peoples for 
the treatment of various ailments [1]. Having less adverse effects and 
promising therapeutic making them to consider as health promoting 
tools. Essential oils are one of them. Monoterpenes, a class of terpe-
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nes under the EOs are now evident to have a good 
number of biological activities [2, 3].
Nerol (cis-2,6-dimethyl-2,6-octadien-8-ol), a 
monoterpene has potential biological activities in 
various in vitro and in vivo test systems [1]. Stu-
dies regarding its action on the central nervous 
system (CNS) with antidepressant, anxiolytic, an-
tinociceptive and anticonvulsant, along with the 
antioxidant, anti- inflammatory, antimicrobial and 
anthelmintic activities [4-7]. To be mentioned that 
nerol is found in various medicinal plants, those 
are reported to have significant antioxidant, an-
timicrobial and neuroprotective activities [8-10]. 
Furthermore, nerol is used as a fragrance in cos-
metics and toiletries [11].
However, naturally occurring substances reveals 
therapeutic alternatives for the neglected diseases 
(ND), which are a group of illnesses representing 
mortality in a race-independent manner of peo-
ple worldwide [12]. People from the remote rural 
areas, urban slums or conflict zones are the most 
susceptible in this context. RDs are not only directly 
affect health, but also represent a vicious cycle of 
socio-economic events that reinforce the feedback 
on the other [13]. It is noteworthy that the existing 
therapies for the RDs are largely based on drugs ha-
ving toxicity and prone to serious side effects, which 
leading to search new agents with more effectively 
and safety [12].
Therefore, this study aimed to carry out a sys-
tematic revision in a scientific and technological 
viewpoint on monoterpenes with the applications 
to NDs underlying a special attention to nerol.
Materials and methods
For articles we searched in the following databases 
of CAPES Periodicals (http://www.periodicos.capes.
gov.br), ScienceDirect (http://www.sciencedirect.
com) and PubMed (http://www.ncbi.nlm.nih.gov/
pubmed) while National Institute of Industrial Pro-
perty of Brazil (INPI), European Patent Office (EPO), 
World Intellectual Property Organization (WIPO) 
and United States Patent and Trademark Office 
(USPTO) databases were considered for patents. 
Evidences having same information were replaced 
by the newer. 
Search (until November, 2015) has been made 
with the listed keywords as ‘monoterpenes’, ‘nerol’ 
and were them paired with ‘neglected diseases’, 
‘malaria’, ‘leprosy’, ‘leishmaniasis’, ‘dengue’, ‘chagas 
disease’, ‘tuberculosis’ and ‘schistosomiasis’. No lan-
guage restrictions were imposed. 
Findings
Scientific and technological
In the search for articles, periodicals and magazi-
nes, monoterpenes constitute 57 periodicals, and 
98 articles in CAPES, PM and SD in which SD oc-
cupied 61.29% while CAPES and PM by 36.77% 
and 1.94%, respectively. Among the 213 evidences, 
66.19% articles belong to the database, SD leaving 
27.23% periodicals, and 6.57% articles behind the 
CAPES and PM, respectively. However, patents sear-
ched in the databases, demonstrating that WIPO 
constitutes 47.06% then followed by 41.18% and 
11.76% in EPO and INPI, respectively for mono-
terpenes. No patents were found in the USPTO. 
Otherwise, nerol constitutes 76 patents, among 
which 98.68% belongs to USPTO leavig behind 
1.32% of WIPP database. No patents were funded 
in INPI and EPO databases (Table 1). 
Table 2 suggests that evidences (periodicals, 
magazines and articles) on malaria (41.11%) are 
prominent for nerol then followed by tuberculosis 
(25.89%), dengue (8.12%) = leprosy (8.12%), schis-
tosomiasis (6.59%) and leishmaniasis (5.08%) = 
chagas disease (5.08%), respectively. More evidence 
was found in SD, which was then followed an order 
of CAPES>PM. Patent search compromised with an 
order of malaria (30.00%)> leishmaniasis (22.50%)> 
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tuberculosis (20.00%)> dengue (15.00%)> leprosy 
(7.50%)> schistosomiasis (5.00%)> chagas disease 
(0.00%). USPTO constitutes 98.75% patents, while 
WIPO by 1.25%. no patents were observed in INPI 
and EPO databases. 
Figure 1 telling that IL is the owner of 31.06% 
patents on NDs, which was then followed an or-
der of AW> US> CA> MA=NL=PA> AT=IN=LU> 
BS=FG=GA=IT=JP=ML=NO=UY, respectively. 
Patients were found from 1992 to 2014 suggest 
in 2004, 2009 and 2013 costitute 8 of each then 
followed by the order of 2010 (7)> 2007 (6)> 2003 
(5) = 2006 (5)> 2000 (4) = 2001 (4) = 2012 (4)> 
1997 (3) = 2002 (3) = 2014 (3)> 1992 (1) = 1994 (1) 
= 1995 (1) = 1999 (1) = 2011 (1), respectively. 
Findings on neglected diseases (NDs)
Antimalarial activity 
Terpenes are the potential sources of antimalarial 
activity [14]. Choloroform extract of Couroupita 
guianensis fruit was found to act against a num-
ber of pathogenic microbes including mycobac-
teria. It also significantly inhibited the formation 
of biofilm of the pathogens [15]. EOs in the leaf 
extract of Plinia cerrocampanensis was found to 
produce significant antimalarial activity [16]. Kpo-
Table 1. Databasic evidences of monoterpenes and nerol in neglected diseases (after sorting). 
Substances
Articles, periodicals and magazines Patents
CAPES PM SD INPI EPO USPTO WIPO
Monoterpenes 57 3 95 2 7 0 8
Nerol 58 14 141 0 0 75 1
PM: PubMed; SD: ScienceDirect; INPI: National Institute of Industrial Property of Brazil; EPO: European Patent Office; WIPO: World Intellectual 
Property Organization; USPTO: United States Patent and Trademark Office.
Table 2. Neglected diseases-wise databasic evidences of nerol.
Neglected 
diseases (NDs)
Articles, periodicals and magazines Patents
CAPES PM SD INPI EPO USPTO WIPO
Malaria 38 2 45 0 0 23 1
Dengue 7 2 7 0 0 12 0
Schistosomiasis 0 3 10 0 0 4 0
Tuberculosis 3 2 48 0 0 16 0
Leprosy 0 0 16 0 0 6 0
Leishmaniasis 0 1 9 0 0 18 0
Chagas disease 0 4 6 0 0 0 0
PM: PubMed; SD: ScienceDirect; INPI: National Institute of Industrial Property of Brazil; EPO: European Patent Office; WIPO: World Intellectual 
Property Organization; USPTO: United States Patent and Trademark Office.
Figure 1:  Patients on neglected diseases belon-
ging to the owners with percentage 
occupied.
AW: Aruba; BS: Bahamas; CA: Canada; FJ: Fiji; GA: Gabon; GB: United Kingdom; IL: 
Israel; IN: India; IT: Italy; JM: Jamaica; JP: Japan; LU: Luxembourg; MA: Morocco; ML: 
Mali; NL: Netherlands; NO: Norway; PA: Panama; US: United States; UY: Uruguay
InternatIonal archIves of MedIcIne 
sectIon: toxIcology & therapeutIcs
ISSN: 1755-7682
2016
Vol. 9 No. 110
doi: 10.3823/1981
This article is available at: www.intarchmed.com and www.medbrary.com 4
viessi et al. founded EOs from the genus Cymbo-
pogon having a potential anti-Trypanosoma bru-
ceibrucei and anti-Plasmodium falciparum activity 
[17]. EOs from Lippia multiflora is also evident 
to act against P. falciparum [18]. The ethanol ex-
tract of Ocimum sanctum is also evident to have 
antimalarial capacity [19]. An in vivo antimalarial 
activity was demonstrated with the allylic alcohol, 
geraniol by [20]. Parshikov et al. also introduced 
few new terpenes with anti-malaria activity [14]. 
A number of EOs derived from plants, including 
monoterpenes were introduced having mosquito 
repellent potential by Pohlitet al. [21]. Nanocapsu-
les prepared with onopordopicrin, a sesquiterpe-
ne was suggested to have a significant antimalaria 
activity [22]. 
Activity against dengue
Conti et al. reported that the Aede salbopictus lar-
vae are susceptible to the EOs of Achillea millefo-
lium, Lavandula angustifolia, Helichrysum italicum, 
Foeniculum vulgare, Myrtus communis, and Ros-
marinus officinalis [23]. EOs of the leaves of Salvia 
dorisiana, S. longifolia, and S. sclarea under the fa-
mily, Lamiaceae exhibited potent anti-A. albopictus 
activity [24]. Additionally, EOs from Citrus sinensis, 
C. limon and C. paraíso shells and its components 
were found to exhibit larvicidal potential against a 
number of mosquito [25]. Pohlit et al. did a revision 
demonstrating EOs to have promising mosquito re-
pellent capacity [21]. 
A research conducted by Pandey et al. of eugen-
yl acetate, linalyl acetate, terpinyl acetate, menthyl 
acetate, geranyl acetate along with the monoterpe-
nes eugenol, linalool, terpineol, L-menthol and ge-
raniol suggesting significant anti-A. aegypti activity 
with an LC50 value range between 50.2 to 415 ppm 
[26]. A research done by Nyasembe et al. suggests 
that volatile phytochemicals may be good options 
for to repeal mosquito [27]. 
Anti-schistosomiasis activity
Mors et al. sugegsted all-trans (-)-14,15-epoxygeran-
yl-geraniol to have a potential anti-schistosomiasis 
activity [28]. Thymol, β-citronellol, carvacrol and ge-
raniol strongly inhibited snail-vector of Schistosoma 
mansoni [29]. EOs isolated from Cymbopogon win-
terianus exhibited significant anti-schistosomiasis 
activity between the LC50 value of 22.0 and 181.0 
mg/L [30].
Anti-tuberculosis potential
EOs from C. guianensis fruit was found to act My-
cobacterium tuberculosis [15]. Kumar et al. obser-
ved that the Plumeria bicolor extract significantly 
inhibited the growth of M. tuberculosis and multi-
drug resistant M. tuberculosis. Along with nerol, 
plumericin and isoplumericin were claimed as a po-
tential candidate for antituberculosis activity. The 
antituberculosis activity of EOs was also observed 
by Kumar et al. with Plumeria bicolor extract [31]. 
The meso-dihydroguaiaretic also exhibited a po-
tential anti-M. tuberculosis [32]. According to Chin-
sembu EOs may be one of the potential sources of 
antituberculosis activity [33]. 
Anti-leprosis activity
Ross suggested that thymol (a natural monoterpene 
phenol derivative of cymene) has an anti-leprosis 
activity [34]. In 1955 Floch and Gelard also demons-
trated similarly [35]. 
Anti-leishmaniasis and anti-chagas disease 
potentials
Monoterpenes with this type of activity is still to 
be investigated, despite of a number of medicinal 
plants have been introduced having anti-leishma-
niasis potential [36-44]. Saponins from Calliandra 
pulcherrima and Quillaja saponaria were found to 
exhibit significant anti-leishmaniasis activity against 
Leishmania donovani and L. chagasi. [45]. Two mo-
noterpenes, minutin A and B from purified from 
Micromelum minutum leaves acted against Leish-
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mania major with IC50 values between 9.8 to 26.2 
μM [46]. EOs from Thymus capitellatus are evident 
to produce strong anti-leishmaniasis activity within 
the IC50 between 35 to 62 μg/mL [47]. Otherwise, 
Morais et al. founded a few thymol and eugenol 
derivatives having potent anti-leishmaniasis activity 
[48]. 
Conclusion
Consistent with the obtained results, we observed 
a significant number of scientific papers and pa-
tent deposits involving monoterpenes and nerol. 
Although, there are links with neglected diseases, 
but found evidences in databases are firmly defi-
cient with specific activities, despite of a number 
of essential oils are evident to have activity against 
neglected diseases. More research is requested in 
this field of study.
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